Healthcare Asia Summit 2022

Mohan Ravuru is a physician researcher with over 15 years’ experience in In-Vitro diagnostics and biopharma industry. He has performed basic, clinical and translational research in Immunology, Infectious diseases and Molecular biology in academia and industry. As director of medical and scientific affairs for Abbott Rapid Diagnostics in Asia Pacific region he oversees the Infectious Diseases portfolio for Emerging Markets. Previously,  he managed the donor blood screening portfolio for HIV, Hepatitis as well as emerging and re-emerging infectious diseases for Grifols. Earlier he served in a global medical affairs role with GSK Biologicals to support clinical development, launch and post-launch activities of vaccines for invasive pneumococcal and meningococcal infections worldwide. His first foray into industry was with Becton Dickinson research and development under Immunization division. Prior to that, he served as clinical research fellow at National University Hospital and Changi General Hospital in Singapore.

Beyond his MD degree, he has a Masters’ degree in cancer immunotherapy from National University of Singapore and a technology management degree from University of Queensland, Australia.  

Alex Boulton is a partner in our Private Equity and Healthcare practices, based in our Singapore office.

Since joining Bain in 2010, Alex has led numerous investment strategy, commercial due diligence and portfolio value creation initiatives across sectors, with a client portfolio that encompasses growth and buyout funds, hedge funds, sovereign wealth funds, infrastructure funds and asset management firms.

He has extensive experience across the Asia-Pacific healthcare sector and is deeply versed in mergers & acquisitions (M&A), full potential strategy and performance improvement.

He holds a BSc in Economics, with First-Class Honours, from the London School of Economics and Political Science.

Chris is a Partner at Pureland Venture, looking after value creation activities for post-investment scale-up of healthtech innovation companies.  In addition, Chris moreover serves in the KPMG Global Health Centre of Excellence and as a strategic advisor for policy dialogue at APACMed (with a particular focus in the digital health domain).  Chris holds additional healthcare ecosystem roles too ranging from public/private UHC design taskforces through to visiting lectureship at leading academic centres.  Chris is presently based in Singapore, having lived and worked around the globe; he is most passionate about bringing safe, effective, economically-viable medical innovations to those populations in need.

Abhay primarily serves life sciences, health care, and private equity clients in Southeast Asia. With his wide-reaching experience in health care strategy and technology, he focuses on advising clients on their transformation agenda; strategic planning efforts; overall portfolio strategy; and growth, market entry and acquisition strategies. He also advises clients on liquidity and working capital management, market attractiveness for new business ventures, initial public offering readiness, and post-merger integration and divestitures. He earned a bachelor’s degree in Accounting and Economics from St. Stephen’s College of Commerce and an MBA from National University of Singapore. 

Nick has been working in Acoustics since leaving university in 1978.   

After working for various small consultancy firms, he joined Arup in 1987, working initially in Hong Kong.  His work included the acoustic design of the new airport terminal and an overseeing role in the noise issues associated with the new railways built at that time, along with acoustic design input to various healthcare projects.   

Nick moved back to the UK in 1994 and worked in Arup’s office in Cambridge on a wide variety of projects in the UK and Europe.  He worked as an acoustic designer and reviewer for a number of large hospital developments around the UK, as well as a range of other building acoustics projects.  During this time, he was part of the team tasked with writing the guidelines for acoustic design in UK healthcare buildings (HTM 08-01) 

In 2009, Nick moved to Singapore with Arup to lead the acoustics and theatre design team.  Local acoustic projects undertaken by Arup included the National Centre for Infectious Disease and various large arts venues and other buildings of note.  Nick was also a lecturer for the Building and Construction Authority in Singapore, presenting a module on Acoustics as part of the Greenmark Professional qualification. 

After spending 5 years in Singapore, Nick relocated to Arup’s office in Melbourne and has worked on various small and large healthcare projects in Australia and Asia along with major performing arts projects around Australia.  He currently leads Arup’s Arts and Culture team in the region. 

Thalia leads Asia Care Group, a specialist management consulting firm focused on the delivery of healthcare strategy, financing, and transformation engagements.

Thalia has 20 years’ senior healthcare management experience and has worked across the industry – with Governments, public and private payors and providers, investors, development organizations, and life science firms on complex system change. Her principal areas of focus are health system strengthening and reform and social and commercial insurance design. She has served an international clientele including advising multiple governments in Asia on health reform and working with many MNC clients on market access and expansion in the region. Prior to coming to Asia, she held senior roles in the UK’s NHS and Department of Health, including heading the Public Health Office for London.

Aditya Agarwal is a Principal with Roland Berger in Singapore. He is a core member of the Healthcare and Life Sciences practice, serving clients on a range of strategic and performance improvement issues.

Ms. Artirat Charukitpipat, Chief Executive Officer of Bumrungrad International Hospital, has been with Bumrungrad International Hospital since January 2012. She plays a significant role as the organization's leader with over 25 years of experience managing many hospitals in Thailand, notably Bangkok Dusit Medical Services, Samitivej Hospital, and Vejthani Hospital. Prior to her term as Bumrungrad’s CEO, she was appointed as the COO, CAO, and CHRO of the hospital.

Every day she leads in ensuring patients are safe while receiving quality care, she also seeks new opportunities and initiating any strategic developments necessary for business sustainability and managing business finances. Regularly, she strengthens the relationships among the Public Private Sector (PPP) including the Ministry of Public Health (MOPH), Ministry or Foreign Affairs (MOFA), Bangkok Metropolitan Administration (BMA), along with several other non-ministerial government agencies, including embassies, and public and private hospitals both domestically and internationally. Furthermore, she expands Bumrungrad’s extensive medical services to the people throughout Thailand by partnering with non-medical businesses including Siam Piwat, Central Group, The Mall Group, Ananda Development, and Sansiri to promote Bumrungrad’s customized medical and wellness plans.

Ms. Artirat has devoted her time to Bumrungrad wholeheartedly. She leads the hospital through innovation, including adopting the latest medical technologies to ensure the patients receive a positive experience with the best clinical outcomes. She works hard to sustain a unique corporate culture-- Agility, Innovation, Compassionate Care are the key terms.

As a result, Bumrungrad stands out as a quaternary care provider, offering highly specialized and complex care through advanced innovation. Bumrungrad has long been a leader in medical tourism, with 1.1 million visitors per year. Over 520,000 of Bumrungrad’s 1.1 million patients are international patients, visiting from over 190 countries.

Bumrungrad has gained a great reputation globally and has been praised by many top organizations. Recently, Newsweek ranked Bumrungrad as the best hospital in Thailand (“World's Best Hospitals 2022 – Thailand”) for the second year in a row. Bumrungrad is also the only Thai hospital on their list of the top 150 hospitals in the world (“World's Best Hospitals 2022”). The hospital achieved “Most Trusted Hospital Brand,” at the Bangkok Post Reader's Choice Awards 2021. Other recent achievements include: “Best Organization in Innovation and Knowledge” at the MIKE Awards 2021, “Human Rights Best Practice Organization in 2021, Quality Persons of the Year 2019” – Ms. Artirat Charukitpipat, in the medical sector from the Foundation of Science and Technology Council of Thailand (FSTT), “Outstanding Level in the Field of Financial Management Excellence” at the Thailand Corporate Excellence Awards 2019.

Ms. Artirat was also named one of the Bangkok Post’s Women of the Year in 2022. She is a woman who inspires society and makes significant changes to society with her dedication to improve healthcare. She is a woman who fosters innovation and has a strong leadership role in the country’s medical industry.

As for her educational background, Ms. Artirat has a Bachelor of Science in Pharmacy from Chulalongkorn University, a Master of Science in Human Resource Management from Sasin Graduate Institute of Business Administration, and a Master of Science in Strategic Marketing Management from Assumption University.

Stella Ramette is Director, Customer Relations & Sales, South East Asia for InterSystems. Based in Singapore, she has over 20 years of experience in healthcare IT, diagnostics, medical imaging, and medical technology. Stella studied nursing at Malmö University and holds a Master of Science and Business Administration from Lund University.

Mohd Daud Mohd Arif took office as the Chief Executive Officer of Malaysia Healthcare Travel Council (MHTC) on 5 April 2021. Previously, he served as the Senior Director of Tourism Policy and International Affairs Division at the Ministry of Tourism, Arts and Culture Malaysia, and Lead Shepherd of the APEC Tourism Working Group.

With 20 years of leadership, Mohd Daud brings a fresh perspective to Malaysia Healthcare’s growth, furthering the country’s vision to be the leading global healthcare destination. In his previous capacity, Mohd Daud has demonstrated fervent passion for raising Malaysia Healthcare’s profile through numerous collaborative initiatives. This includes co-organizing the APEC Forum on Medical Tourism with MHTC, themed Building a Borderless Future in Healthcare, and jointly representing and promoting Malaysia’s healthcare travel industry at the Standing Committee for Economic and Commercial Cooperation of the Organisation of Islamic Cooperation (COMCEC) Tourism Working Group Meetings among others.

A firm believer in collaboration for industry advancement, Mohd Daud has dedicated a significant number of years to cross-border efforts in boosting the nation’s tourism industry. To that extent, he holds an extensive portfolio through positions held as the Director of Tourism Industry Development, the Director of Culture and Tourism at the ASEAN-Korea Centre, and Chair of several international committees, including the ASEAN Tourism Professional Committee, COMCEC Standing Committee, and ASEAN-KOREA Tourism Working Group.

He holds a Bachelor’s degree in Economics from McGill University, Canada, and a Master’s degree in International Relations from Waseda University, Japan. Mohd Daud has several awards under his belt including the Ontario Scholar's Award, Graduate School Valedictorian, and the UNWTO Ulysses Award for Innovation in Public Policy and Governance for The Malaysia Homestay Experience Programme.

Mohd Daud is a loving husband and a proud father of four who enjoys keeping up a healthy lifestyle through his love for cycling. With a heart for improving lives and investing in the nation’s socio-economic development, he supports many charitable organizations including Mercy Malaysia, United Nations International Children's Emergency Fund (UNICEF), and the National Kidney Foundation. Mohd Daud looks forward to optimising his new role to fulfill his passion for nation-building, giving his best in every upcoming undertaking.

Senior Healthcare Executive with over 16 years of experience in hospitals, ambulatory care clinics, healthcare IT, consultancy projects, multi-site management, and with an excellent understanding of hospital processes. Championed special go-to-market strategy, turnaround projects, cost efficiency, revenue generation, hospital design to launch, and quality & process improvement projects across all the departments in hospitals. Experience in leading the successful completion of real-time 35 Joint Commission International and 60 National Accreditation Board for Hospitals & Healthcare Providers surveys at various hospitals. “Out of the box” thinker with excellent communication, analytical, and leadership skills. Successfully organized support projects to position the organization as a top healthcare provider.

Administrator Surveyor, Joint Commission International, US (Surveyed in China, Taiwan, Middle East, Japan, Europe, South Korea, South East Asia, etc)

Member, expert panel to review NABH standards (Ambulatory care) & CII for various projects

A/Prof LE THI ANH THU, MD, PhD, is Group Chief Medical Officer of Hoan My Medical Corporation. She also has a role as President of Viet Nam Infection Control Society (VNICS) and Ho chi Minh city Infection Control Society  (HICS). She is consultant and expert for Ministry of Health, for Department of Health of Ho chi Minh city and is a teacher for Pham Ngoc Thach University of Medicine.

She has experiences of working as Infectious diseases specialist for 10 years and has been working as hospital epidemiologist, infection control consultant for more than 25 years. She is participating in the National Writing Committee to develop guidelines and policies in infection control for the Ministry of Health.  She has been chief investigator for many important researches funded by the Vietnamese Government and WHO. Her recent researches are mainly in infection control, hospital epidemiology, risk and patient safety. She is the author of more than 75 publications and books and presented in more than 35 international conferences.

Dr. Thirunavukarasu Rajoo is currently the Honorary General Secretary of the Malaysian Medical Association, which is the largest and oldest medical association in Malaysia. He was the Chairman of the Private Practitioner Section of the Malaysian Medical Association since 2017. He is also the Chief Executive Officer of CareClinics Healthcare Services Sdn Bhd, which operates 28 General Practice Clinics mostly located in the greater KL.

He is representing MMA in various national committees. Some of the committees that he is a member are:
1. National Medicine Policy
2. National Antimicrobial Resistance Committee
3. National Committee on the Managed Care Organisation
4. Malaysian Adverse Drug Reactions Advisory Committee
5. Private Healthcare Productivity Nexus
6. Drug Control Authority 

He also initiated 3 major studies for General Practitioners:
1. Dispensing Separation: Perception of Public Visiting Primary Care Clinics in Malaysia. 2016
2. A Study on the Health Economics of General Practitioners in Malaysia: Trends, Challenges, and Moving Forward. 2017
3. Knowledge, Attitude & Perception of General Practitioners towards NCDs.

He is also actively involved in various negotiations concerning the General Practitioners on major issues affecting the practice, namely:
1. Dispensing Separation - RUUF Port Dickson. 2015
2. 7th Fee Schedule for General Practitioners
3. Managed Care Organisations
4. Enhancing General Practice
5. Medicine Price Control
6. Online Healthcare Services, the Need for Legal Framework.

Dr. Thirunavukarasu Rajoo has been the voice of General Practitioners. He was invited to lead the General Practitioners at the town hall meeting attended by 1000 General Practitioners with the then Honorable Minister of Health, Malaysia.

He has been in the practice of medicine for the last 14 years. Dr. Arasu, as known among the fraternity is also a practicing General Practitioner and founded the Poliklinik Cahaya group of clinics and recently CareClinics Healthcare Services Sdn Bhd. His group practice operates 25 clinics in the greater Kuala Lumpur, with all the clinics are connected via Electronic Medical Records. Recently, a Personal Health Record was also launched as pilot for 2 of the clinics, whereby patients’ health records are pushed to the patient via the app. His group adopts to IR4.0 and moving toward patient-centered care and value-based healthcare by adopting innovation and technology that benefits the patients.

He was a member of the Greater Klang Valley COVID-19 Task Force and Technical Working Group (TWG) PPP Primary Care under the Health and Sciences COVID-19 Advisory Group of Experts (EAG).

Dr Zaw Win Sandy was born and brought up in Myanmar and received her Bachelor of Medicine; Bachelor of Surgery (MBBS) from University of Medicine (1) Yangon in 2007. She started her career as a Resident House Surgeon at Yangon General Hospital in 2006.  

After completion of her Master of Business Administration (MBA) with a specialization in talent management including workforce planning, recruiting, performance management, employee development, and employee engagement from James Cook University (Australia) in 2009, she joined as a Clinic Operating Manager at City Health Clinics chain in Singapore. 

In 2011, Dr. Sandy decided to come back home and took up a role as Customer Relation Manager at Pun Hlaing International Hospital. She rose through the ranks to be appointed as the Interim Talent Management Director in 2014. Subsequently, in 2015, she was promoted to Talent Management Director of the new Pun Hlaing Siloam Hospitals joint venture. 

In this role, she was responsible for Manpower Planning, recruitment and retention, career development, and general HR. In addition to this role, she also led the hospital operation on CRM, Patient Experience, and Front Office service. 

In January 2019, Dr. Sandy was promoted to head of the flagship Hlaing Tharyar Hospital operations in addition to her group role in charge of Social Media and CRM. 

In May 2020, Dr. Sandy was promoted to head the new vertical of Emerging Healthcare, an exciting business and operational proposition designed to the traditional brick and mortar operations with the ubiquitous virtual platform. Under Emerging Health, heal by Pun Hlaing (Health Empowerment and Active Living) brand was launched together with its family practitioner clinics, mobile app, and other clinical-related services in the pipeline. This vertical would set Pun Hlaing Hospitals (PHH) to drive its reach across the country using its existing infrastructure, and amalgamated to preferred suppliers, both in the primary and secondary sector. As COO of this vertical, Dr. Sandy envisages to help PHH grow to become the largest healthcare network in Myanmar within the next 5 years. 

Academic Background 

• Bachelor of Medicine; Bachelor of Surgery (MBBS) in 2007, University of Medicine 1 Yangon, Myanmar.  

• Master of Business Administration (MBA) in 2009, James Cook University (Australia)  

• Harvard Alumni (Harvard Medical School, Medical Leadership Program) in 2020 

• Certified Health Executive (the Australasian College of Health Service Management (ACHSM)) in 2021 

• Fellow of the Australasian College of Health Service Management (FCHSM) in 2021 

Currently Working as Regional Chief Operating Officer at Healthcare Global Enterprises Ltd, Manisha Kumar has over 14 years of experience heading Super Specialty hospitals across the country. She is known for her expertise in healthcare business turnaround and startup and growth strategy. She is an MBA from Indian School of Business and started her business career early – she has guided several healthcare startups and has been deeply involved in managing COVID pandemic in her state in the last 2 years. For her accomplishments, she has been a recipient of several national and global awards and has recently been ranked in the elite list of 40 Under 40 business leaders by BusinessWorld magazine in 2022.

Being a full board scholar of Tenaga Nasional Berhad (“TNB”), Ariesza served in TNB and 
has held various financial and accounting roles from 1999 onwards. 

Ariesza was appointed the Vice President of Investor Relations and Corporate Communications of IHH Healthcare Berhad in 2012 and oversaw the Company’s IPO in Malaysia and based on its highest Malaysian share price of RM3.19 (at the time), IHH has a market capitalisation of RM25.6 billion, making it the world's second-biggest listed healthcare provider after U.S. hospital operator HCA Holdings Inc.

She has also served as the Vice President, Group Strategy and Operations for WASCO Energy, a multinational oil and gas services company owned by Wah Seong Corporation Berhad for a cumulative 11 years. At WASCO, she oversaw the Group’s branding, marketing, strategic planning, and M&A activities. In addition, she played a leading role in WASCO’s major pipe coating operations in Malaysia. She came onboard KPJ in March 2021 as Chief Corporate Officer.

Ariesza holds a B.COM (Hons) Accounting & Finance, from Lincoln University, New Zealand. She is also a Fellow of CPA Australia.

Dennis L. Sta. Ana, MD, MHM, FACS

Aside from his medical practice as a surgeon, Dr. Sta. Ana holds key positions in different enterprises. He is currently the President and CEO of Makati Life Medical Center.

A visionary leader, Dr. Dennis is also the President of Life Nurture Inc. (LNI), a company engaged in diverse healthcare businesses. He is also the Founder and President of Quality Management Solutions, a medical BPO, and MII Healthcare, a multi-brand pharmaceutical firm.

Dr. Sta. Ana is the former President of Batangas Health Medical Center and Department Chair of Surgery of Diliman Doctors Hospital.

He sits as a Board Member, a major stockholder, and a Medical Director of Diliman Doctors Hospital. He holds a Master's Degree in Hospital Administration and completed General Surgery training at The Medical City in Pasig after obtaining his medical degree at the University of Sto. Tomas.